Follow
Georg F Weber
Georg F Weber
Unknown affiliation
Verified email at uc.edu
Title
Cited by
Cited by
Year
Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity
S Ashkar, GF Weber, V Panoutsakopoulou, ME Sanchirico, M Jansson, ...
Science 287 (5454), 860-864, 2000
14722000
Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
GF Weber, S Ashkar, MJ Glimcher, H Cantor
Science 271 (5248), 509-512, 1996
12301996
Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes
TKH Chang, GF Weber, CL Crespi, DJ Waxman
Cancer research 53 (23), 5629-5637, 1993
7311993
The metastasis gene osteopontin: a candidate target for cancer therapy
GF Weber
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1552 (2), 61-85, 2001
4652001
Phosphorylation‐dependent interaction of osteopontin with its receptors regulates macrophage migration and activation
GF Weber, S Zawaideh, S Hikita, VA Kumar, H Cantor, S Ashkar
Journal of leukocyte biology 72 (4), 752-761, 2002
3342002
Osteopontin is a marker for cancer aggressiveness and patient survival
GF Weber, GS Lett, NC Haubein
British journal of cancer 103 (6), 861-869, 2010
2342010
Absence of the CD44 gene prevents sarcoma metastasis
GF Weber, RT Bronson, J Ilagan, H Cantor, R Schmits, TW Mak
Cancer Research 62 (8), 2281-2286, 2002
2212002
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3
A Kumar, Y Zhao, G Meng, M Zeng, S Srinivasan, LM Delmolino, Q Gao, ...
Molecular and cellular biology 22 (16), 5801-5812, 2002
2182002
An osteopontin splice variant induces anchorage independence in human breast cancer cells
B He, M Mirza, GF Weber
Oncogene 25 (15), 2192-2202, 2006
2072006
The immunology of Eta-1/osteopontin
GF Weber, H Cantor
Cytokine & growth factor reviews 7 (3), 241-248, 1996
1991996
Osteopontin‐c is a selective marker of breast cancer
M Mirza, E Shaughnessy, JK Hurley, KA Vanpatten, GA Pestano, B He, ...
International journal of cancer 122 (4), 889-897, 2008
1652008
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix …
C Mesa Jr, M Mirza, N Mitsutake, M Sartor, M Medvedovic, C Tomlinson, ...
Cancer research 66 (13), 6521-6529, 2006
1602006
Why does cancer therapy lack effective anti-metastasis drugs?
GF Weber
Cancer letters 328 (2), 207-211, 2013
1572013
Glutathione peroxidase deficiency and childhood seizures
GF Weber, P Maertens, X Meng, CE Pippenger
The Lancet 337 (8755), 1443-1444, 1991
1571991
Molecular mechanisms of metastasis
GF Weber
Cancer letters 270 (2), 181-190, 2008
1502008
Interaction between CD44 and osteopontin as a potential basis for metastasis formation.
GF Weber, S Ashkar, H Cantor
Proceedings of the Association of American Physicians 109 (1), 1-9, 1997
1491997
Osteopontin-c splicing isoform contributes to ovarian cancer progression
TM Tilli, VF Franco, BK Robbs, JLM Wanderley, FRA da Silva, ...
Molecular Cancer Research 9 (3), 280-293, 2011
1182011
A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells
XF Yang, GF Weber, H Cantor
Immunity 7 (5), 629-639, 1997
1081997
Molecular mechanisms of cancer
GF Weber
Springer 39, 45-99, 2007
1052007
Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death
GA Pestano, Y Zhou, LA Trimble, J Daley, GF Weber, H Cantor
Science 284 (5417), 1187-1191, 1999
1041999
The system can't perform the operation now. Try again later.
Articles 1–20